PSIL logo

PSIL ETF

Profile

Name:

AdvisorShares Psychedelics ETF

Assets under management:

$7 M

Expense ratio:

0.60%

Inception date:

16 September 2021

Last ex-dividend date:

23 September 2024

Next ex-dividend date:

N/A

Description:

The PSIL ETF is an exchange-traded fund that focuses on companies involved in the psychedelic industry. It aims to provide investors with exposure to businesses developing psychedelic therapies and related products, promoting mental health and wellness. The fund offers a way to invest in this emerging market.
Name
Weight
CYBN logo
Cybin(CYBN)
7.50 %
5.81 %
ALKS logo
Alkermes(ALKS)
5.46 %
5.30 %
BLACKROCK TREASURY TRUST INSTL 62
5.24 %
5.16 %
5.16 %

Holding types

Countries

Sectors

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)
PSIL
Benzinga13 April 2023

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.

Cannabis Is A Psychedelic - Dr. Julie Holland
Cannabis Is A Psychedelic - Dr. Julie Holland
Cannabis Is A Psychedelic - Dr. Julie Holland
PSIL
Seeking Alpha26 March 2023

Dr. Julie Holland on why cannabis is a psychedelic. The biggest risk in psychedelic treatment.

FAQ

  • What is PSIL ETF?
  • Does PSIL pay dividends?
  • What stocks are in PSIL ETF?
  • What is the current assets under management for PSIL?
  • What is PSIL average volume?
  • What is PSIL expense ratio?
  • What is PSIL inception date?

What is PSIL ETF?

The PSIL ETF is an exchange-traded fund that focuses on companies involved in the psychedelic industry. It aims to provide investors with exposure to businesses developing psychedelic therapies and related products, promoting mental health and wellness. The fund offers a way to invest in this emerging market.

Does PSIL pay dividends?

Yes, the AdvisorShares Psychedelics ETF does pays dividends, with the most recent payment being $0.11 per share. The last ex-dividend date was on 23 September 2024, and the next ex-dividend date has not been announced yet

What stocks are in PSIL ETF?

As of today, AdvisorShares Psychedelics ETF inlcudes 27 holdings, with 18 of them being companies from 6 different countries and 1 sectors. The most weighted holdings are Mind Medicine (MindMed) (12.1%), Atai Life Sciences NV (7.92%) and Cybin (7.5%)

What is the current assets under management for PSIL?

Assets under management of AdvisorShares Psychedelics ETF is $7 M

What is PSIL average volume?

Average volume of AdvisorShares Psychedelics ETF is $27 K

What is PSIL expense ratio?

Expense ratio of AdvisorShares Psychedelics ETF is 0.60%

What is PSIL inception date?

Inception date of AdvisorShares Psychedelics ETF is 16 September 2021